European Pharmacopoeia
The European Pharmacopoeia (Ph. Eur.) of the Council of Europe is a pharmacopoeia, listing a wide range of active substances and excipients used to prepare pharmaceutical products in Europe. It includes more than 2000 specific and general monographs, including various chemical substances, antibiotics, biological substances; Vaccines for human or veterinary use; Immunosera; Radiopharmaceutical preparations; Herbal drugs; Homoeopathic preparations and homoeopathic stocks. [1] It also contains Dosage forms, General monographs, Materials and Containers, Sutures; 268 General methods with figures or chromatograms and 2210 reagents are described. The monographs give quality standards for all the main medicines used in Europe. All medicines sold in the 36 Member States of the European Pharmacopoeia must comply with these quality standards so that consumers have a guarantee for products obtained from pharmacies and other legal suppliers.
The European Pharmacopoeia is developed by the European Directorate for the Quality of Medicines (EDQM) and is a part of the Council of Europe, Strasbourg, France[2]. It has been created by the Convention on the elaboration of a European Pharmacopoeia from 1964. [3]. Although the Pharmacopoeia is often listed as one of Council of Europe partial agreements, it is not, strictly speaking, a partial agreement. It has a different legal basis from the others, being established as the result of a treaty. The others were established by a "statutory resolution" adopted by the Committee of Ministers. It is published by EDQM in English and French, official national translations are available in German and Spanish (Spanish version only online).
Participating countries
Currently there are 37 members of the European Pharmacopoeia Commission: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Republic of Macedonia, Turkey, United Kingdom, and the European Union [4].
In these countries and the European Union the Ph. Eur. is the official pharmacopoeia. Additional local pharmacopoeias may exist (e. g. in United Kingdom and Germany). Not all of these countries are member states of the European Union.
Observers from 20 member and non-member states of the Council of Europe and international organisations take part on sessions of the European Pharmacopoeial Commission: Albania, Algeria, Australia, Belarus, Brazil, Canada, China, Georgia, Israel, Madagascar, Malaysia, Morocco, Kazakhstan, Russian Federation, Senegal, Syria, Tunisia, Ukraine, United States of America, and the WHO [5].
The convention is open for signature by all European countries. Other countries can get observer status.
Editions
Since its 5th edition, the pharmacopoeia is published in 2 volumes. Volume 1 contains general chapters and monographs (e.g. on dosage forms, methods of analysis, reagents), volume 2 contains all substance monographs. During runtime of current edition several supplements are published. Electronic versions are also available (CD-ROM, USB stick and online version).
- 1st edition: published 1967
- 2nd edition: published 1980
- 3rd edition: published 1997
- 4th edition: published 2001, valid from 1 January 2002
- 5th edition: published 15 June 2004, valid from 1 January 2005
- 6th edition: published 16 July 2007, valid from 1 January 2008
- 7th edition: published July 2010, valid from 1 January 2011 [1]
See also
External links
References
- ^ a b European Pharmacopoeia, 7th edition PDF: Products and Services, Catalogue 2010
- ^ http://www.edqm.eu/en/Homepage-628.html
- ^ http://conventions.coe.int/Treaty/Commun/QueVoulezVous.asp?NT=050&CL=ENG
- ^ "EDQM". Retrieved 13 July 2010.
- ^ "EDQM". Retrieved 13 July 2010.